94 related articles for article (PubMed ID: 11460477)
1. Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2).
Ritchie H; Lawrie LC; Mosesson MW; Booth NA
Ann N Y Acad Sci; 2001; 936():215-8. PubMed ID: 11460477
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
[TBL] [Abstract][Full Text] [Related]
3. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin.
Ritchie H; Robbie LA; Kinghorn S; Exley R; Booth NA
Thromb Haemost; 1999 Jan; 81(1):96-103. PubMed ID: 10348718
[TBL] [Abstract][Full Text] [Related]
4. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures.
Jensen PH; Lorand L; Ebbesen P; Gliemann J
Eur J Biochem; 1993 May; 214(1):141-6. PubMed ID: 8099547
[TBL] [Abstract][Full Text] [Related]
5. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
Achyuthan KE; Dobson JV; Greenberg CS
Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
[TBL] [Abstract][Full Text] [Related]
6. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking.
Jensen PH; Schüler E; Woodrow G; Richardson M; Goss N; Højrup P; Petersen TE; Rasmussen LK
J Biol Chem; 1994 May; 269(21):15394-8. PubMed ID: 7910824
[TBL] [Abstract][Full Text] [Related]
7. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
Kimura S; Aoki N
J Biol Chem; 1986 Nov; 261(33):15591-5. PubMed ID: 2877981
[TBL] [Abstract][Full Text] [Related]
8. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
Matsuka YV; Medved LV; Migliorini MM; Ingham KC
Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
[TBL] [Abstract][Full Text] [Related]
9. Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase.
Scavenius C; Sanggaard KW; Nikolajsen CL; Bak S; Valnickova Z; Thøgersen IB; Jensen ON; Højrup P; Enghild JJ
Biochim Biophys Acta; 2011 Dec; 1814(12):1624-30. PubMed ID: 21939789
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
[TBL] [Abstract][Full Text] [Related]
11. Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking.
Sobel JH; Gawinowicz MA
J Biol Chem; 1996 Aug; 271(32):19288-97. PubMed ID: 8702612
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
[TBL] [Abstract][Full Text] [Related]
14. [Binding of alpha-2-antiplasmin with fibrinogen/fibrin and their fragments independent of factor XIII].
Zadorozhna MB; Hrynenko TV; Iusova OI; Volkov HL
Ukr Biokhim Zh (1999); 2004; 76(5):71-7. PubMed ID: 16100900
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
[TBL] [Abstract][Full Text] [Related]
16. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
[TBL] [Abstract][Full Text] [Related]
17. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
18. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
Shainoff JR; Urbanic DA; DiBello PM
J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: in vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1.
Oji V; Oji ME; Adamini N; Walker T; Aufenvenne K; Raghunath M; Traupe H
Br J Dermatol; 2006 May; 154(5):860-7. PubMed ID: 16634887
[TBL] [Abstract][Full Text] [Related]
20. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
Lijnen HR; Van Hoef B; Matsuo O; Collen D
Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]